07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

5362<br />

FEMA<br />

91836<br />

EMA<br />

9360<br />

anatomic pathology consultation<br />

Interpretation: A neoplastic clone is detected when the percent of nuclei with an abnormality exceeds<br />

the established normal cutoff for the JAZF1 probe set. A positive result of JAZF1 rearrangement is<br />

consistent with a diagnosis of endometrial stromal tumors (EST). A negative result suggests that JAZF1 is<br />

not rearranged, but does not exclude the diagnosis of EST.<br />

Reference Values:<br />

An interpretive report will be provided.<br />

Clinical References: 1. Koontz J, Soreng AL, Nucci M, et al: Frequent fusion of the JAZF1 and<br />

JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 2001;98(11):6348-6353 2. Oliva E,<br />

de Leval L, Soslow RA, et al: High Frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal<br />

tumors with smooth muscle differentiation by interphase FISH detection. Am J Surg Pathol<br />

2007;31(8):1277-1284 3. Nucci R, Harburger D, Koontz J, et al: Molecular analysis of the JAZF1-JJAZ1<br />

gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J<br />

Surg Pathol 2007;31(1):65-70 4. Huang H-Y, Ladanyi M, Soslow RA: Molecular detection of<br />

JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology-evidence<br />

for genetic heterogeneity. Am J Surg Pathol 2004;28(2):224-232<br />

Endomyocardial Biopsy<br />

Clinical Information: Endomyocardial biopsies may be indicated to evaluate a variety of cardiac<br />

disorders. The procedure is performed using a device inserted through the jugular, subclavian, or femoral<br />

vein.<br />

Useful For: Evaluation of: -Cardiac allograft rejection -Cardiomyopathies -Myocarditis -Idiopathic<br />

arrhythmias -Idiopathic chest pain -Anthracycline cardiotoxicity -Secondary heart disease (amyloidosis,<br />

sarcoidosis, hemochromatosis, storage diseases, and neoplastic diseases)<br />

Interpretation: This request will be processed as a consultation. Appropriate stain(s) will be<br />

performed and a diagnostic interpretation provided.<br />

Reference Values:<br />

Abnormalities will be compared to reported reference values.<br />

Clinical References: Edwards WD, Holmes DR Jr: Transvenous endomyocardial biopsy. In <strong>Mayo</strong><br />

Clinic Practice of Cardiology: Fundamentals and Practice. 3rd edition. Edited by ER Giuliani, BJ Gersh,<br />

MD McGooh, et al. St. Louis, MO, Mosby-Yearbook, 1996, pp 672-688<br />

Endomysial (EMA) Antibody (IgG) titer<br />

Reference Values:<br />

Negative: or =1:2.5 titer<br />

Serology Comments<br />

IgG-EMA is generally only significant in those individuals who are IgA deficient and thus cannot<br />

produce IgA-EMA.<br />

<strong>Test</strong> Performed <strong>By</strong>: IMMCO Diagnostics, Inc.<br />

60 Pineview Drive<br />

Buffalo, NY 14228<br />

Endomysial Antibodies (IgA), Serum<br />

Clinical Information: Circulating IgA endomysial antibodies (EMA) are present in 70% to 80% of<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 668

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!